透過您的圖書館登入
IP:3.147.42.168
  • 期刊

One-Year Variation of Fasting Plasma Glucose is a Strong Predictor of Chronic Obstructive Pulmonary Disease in Elders with Type 2 Diabetes Mellitus: The Taiwan Diabetes Study

並列摘要


Background: It has been suggested that patients with diabetes were at risk for developing chronic airflow obstruction that could subsequent incur significant disability due to mechanical dysfunction of the lungs and airways. Glucose stability is one of the goals in the management of diabetes. Thus, the present study examined the association between one-year glucose variation as measured by coefficient of variation (CV) of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) and risk of chronic obstructive pulmonary disease (COPD) in a large number of type 2 diabetes patients followed for an average of 7.02 years. Methods: We conducted a retrospective cohort study on 10,253 type 2 diabetes elders who participated in the National Diabetes Case Management Program in Taiwan. One-year variation of HbA1c and FPG at baseline and COPD events over the 7.02 years was analyzed. Results: There were a total of 1,188 incident cases of COPD. Patients were grouped in tertiles of FPG-CV and HbA1c-CV. The incidence rates for FPG-CV were 14.68, 16.45, and 18.25 per 1000 person years and for HbA1c-CV were 14.68, 16.45, and 18.25 per 1000 person years in the groups of 1st , 2nd, and 3rd tertile, respectively. After adjusting for age, gender, duration of diabetes, type of treatment, smoking, hypertension, hyperlipidemia, FPG-M, HbA1C, and complications, both FPGCV and HbA1c-CV were independently associated with COPD. The hazard ratios of COPD for 3rd versus 1st tertile of FPG-CV were 1.18 (1.02-1.37), whereas the hazard ratios of COPD for 2nd, 3rd versus 1st tertile of HbA1c-CV were 1.17 (1.01-1.35), and 1.21 (1.04-1.40), respectively. Conclusion: Patients categorized as FPG variation greater than 34.43% or more or as HbA1c variation greater than 8.29% or more exhibited an increased risk of COPD, confirming a linear relationship. One-year variation of FPG and HbA1c are strong predictors of COPD in type 2 diabetic patients. Our study findings suggest that we should pay much attention to lung dysfunction in diabetes, with an emphasis on the emerging potential clinical implications of such dysfunction.

延伸閱讀